Antidote is on a mission to catalyze medical innovation by successfully connecting patients and researchers as the best-in-class recruiter for clinical studies. Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. We're based in New York, NY and London, U.K. For more information, visit http://www.antidote.me.
Looking for a particular Antidote Technologies employee's phone or email?
The Antidote Technologies annual revenue was $11.6 million in 2026.
Keith Lovell is the CFO of Antidote Technologies.
27 people are employed at Antidote Technologies.
Antidote Technologies is based in North Miami Beach, Florida.
The NAICS codes for Antidote Technologies are [5415, 541511, 54, 541, 54151].
The SIC codes for Antidote Technologies are [73, 737].